BridgeMD
New treatment option for Epilepsy
Official title Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy
ClinicalTrials.gov ID: NCT06105645
What this study is testing
- What it's testing
- The main aim of this study is to evaluate the contribution of fast-ripples (FR) information on the neurosurgery management of patients with drug-refractory epilepsy investigated by Stereo-ElectroEncephaloGraphy (SEEG), as measured by freedom from disabling seizures one-year post-surgery. 220 patients (for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed) distributed over 5 centres and 220 control patients(who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed) distributed over 6 centres.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patient suffering from drug-resistant focal epilepsy (DRFE), as defined by the International League Against Epilepsy, undergoing SEEG, the indication...
- Patient who has given written informed consent to allow the study data collection procedures
- Patient covered by the French healthcare system.
You likely can't join if
- Patients under juridical protection (authorship, curators or safeguarding of justice).
- Patient deprived of liberty by a judicial or administrative decision
- Patient with a cardiac defibrillator
- Thermocoagulation planned on one of the potential hybrid electrodes .
- Patient in exclusion period of another study.
- No other non-inclusion criteria since the study will only be proposed to patients who already meet the criteria for a SEEG
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
- Bordeaux, France
- La Tronche, France
- Le Kremlin-Bicêtre, France
- Lille, France
- Lyon, France
- Nancy, France
- Paris, France
- Rennes, France
- Strasbourg, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France; Bordeaux, France; La Tronche, France; Le Kremlin-Bicêtre, France; Lille, France; Lyon, France and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.